Under New Ownership, Classic Brands St. Ives and Noxzema Are Ready for a Modern Makeover

Why It Matters

The revitalization of St. Ives and Noxzema gives Evermark a foothold in the premium skincare segment, while offering consumers refreshed, clean‑beauty options. Success could signal how legacy brands can be re‑engineered for Gen Z and millennial demand.

Key Takeaways

• Evermark adds St. Ives, Noxzema to its portfolio.
• Brands will undergo product reformulation and packaging redesign.
• Focus on clean ingredients to attract millennial shoppers.
• Digital and social media campaigns planned for brand revival.
• Expansion into e‑commerce and global markets targeted.

Pulse Analysis

Legacy skincare names like St. Ives and Noxzema have long relied on nostalgic appeal, but shifting consumer expectations around ingredient transparency and sustainability have eroded their market share. Their recent acquisition by Evermark—a holding created to consolidate mass‑market beauty assets—mirrors a wave of private‑equity and strategic buyers snapping up heritage brands at bargain valuations. By bundling these icons with existing assets such as Suave and Pond’s, Evermark aims to leverage shared supply chains and cross‑category expertise, creating economies of scale that were previously out of reach for standalone owners.

Evermark’s turnaround plan centers on a “modern makeover” that goes beyond cosmetic redesign. The company intends to reformulate core products with cleaner, naturally derived actives while eliminating controversial preservatives, aligning with the clean‑beauty movement that dominates millennial and Gen Z purchasing decisions. Sustainable packaging—recyclable tubes and refillable containers—will address growing environmental concerns. Simultaneously, a digital‑first marketing strategy will deploy influencer partnerships, shoppable TikTok content, and data‑driven personalization to re‑engage lapsed customers and attract new fans. By integrating e‑commerce platforms and expanding distribution into emerging markets, Evermark seeks to accelerate revenue growth beyond traditional brick‑and‑mortar channels.

If successful, Evermark’s revitalization could reshape the competitive landscape of mid‑tier skincare, forcing rivals to reconsider how they manage legacy portfolios. A rejuvenated St. Ives and Noxzema could capture market share from both mass‑market incumbents and niche clean‑beauty startups, demonstrating that heritage brands can be re‑engineered for contemporary relevance. Investors will watch closely for early sales lift and brand sentiment metrics, which may set a benchmark for future acquisitions of aging consumer‑goods assets.